BYETTA is a non-insulin type 2 diabetes injection medication for adults. Important Safety Information for BYETTA (exenatide) injection . with prior severe hypersensitivity reactions to exenatide or to any of the product components. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution for injection in pre-filled pen exenatide. Read all of this leaflet carefully.
|Published (Last):||11 March 2010|
|PDF File Size:||13.25 Mb|
|ePub File Size:||18.99 Mb|
|Price:||Free* [*Free Regsitration Required]|
You are encouraged to report negative side effects of prescription drugs to the FDA. Go to Healthcare Professional Site. Not a substitute for insulin and should not be used in patients with type 1 diabetes or diabetic ketoacidosis.
Before taking BYETTA, tell your healthcare provider if you have had pancreatitis, stones in your gallbladder gallstonesa history of alcoholism, or high blood triglyceride levels. Postmarketing reports of serious hypersensitivity reactions eg anaphylaxis and angioedema.
AstraZeneca provides this link as a service to website visitors. This site is intended for US Consumers.
Welcome to BYETTA.com!
Should not be used in patients with severe renal impairment or end-stage renal disease. BYETTA slows gastric emptying and can reduce the extent and rate of absorption of orally administered drugs.
Postmarketing reports of altered renal function, including increased serum creatinine, renal impairment, worsened indert renal failure, and imsert renal failure, sometimes requiring hemodialysis and kidney transplantation. Postmarketing reports of increased international normalized ratio INR sometimes associated with bleeding with concomitant use of warfarin.
Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if inzert cannot take liquids by mouth. Approved Uses BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise. Oral medications dependent on threshold concentrations for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA.
This product information is intended for US Healthcare Professionals only. Use in pediatric patients is not recommended as safety and effectiveness have not been established. To report drug exposure during pregnancy call Stop taking BYETTA and call your healthcare provider right away if you have pain in your stomach area abdomen that is severe, and will not go away, occurs with or without vomiting or is felt going inssert your abdomen through to your back.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
All other trademarks are property of their respective owners. Go to Patient Site. Talk to your healthcare provider first insetr you are breastfeeding or plan to breastfeed.
Symptoms of a severe allergic reaction include severe rash or itching, swelling of your face, lips, and throat that may cause difficulty breathing or swallowing, feeling faint or dizzy and very rapid heartbeat. The site you are about exenaide visit is maintained by a third party who is solely responsible for its contents.
Official BYETTA® (exenatide) injection Healthcare Professional Website
Staying Active Learn how regular physical activity can help you manage type 2 diabetes. When used with insulin, evaluate and consider reducing the insulin dose in patients at increased risk of hypoglycemia. No placebo-treated patients withdrew due to nausea or vomiting.
Use with caution in patients with renal transplantation or when initiating or escalating the dose in patients with moderate renal failure.
Based on animal data, BYETTA may cause fetal harm and should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Unsert Double B logo is a trademark of the AstraZeneca group of companies. If worsening of or failure to achieve adequate glycemic control occurs, consider alternative antidiabetic therapy.
Concurrent use with prandial insulin has not been studied and cannot be recommended. Tell your healthcare provider if you are pregnant or plan to become pregnant.
All other trademarks are property of their respective owners.